Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-21
    E.g., 2018-10-21

Archive Search

2 results
12:00 AM, Sep 07, 2015  |  BC Week In Review | Company News  |  Deals

Mabtech, Sorrento deal

Mabtech granted Sorrento exclusive rights to develop and commercialize four undisclosed biosimilar mAbs in North America …
and that two are under review in China. Sorrento did not respond to inquiries, and Mabtech
could not be reached. Mabtech Ltd. ,   Sorrento Therapeutics Inc. (NASDAQ:SRNE), San Diego, Calif.   …
12:00 AM, Mar 18, 2002  |  BC Week In Review | Company News  |  Deals

Seattle Genetics, Mabtech AB deal

Mabtech granted SGEN an exclusive license to certain monoclonal antibodies that target cell surface molecules on …
with its antibody-drug conjugate (ADC) technology. Under a 1998 deal, SGEN licensed rights to a Mabtech
expect to start clinical testing later this year. Seattle Genetics Inc. (SGEN), Bothell, Wash.   Mabtech